Pharmaceutical companies are changing their approach to strategies and long-term goals as a result of new data and analytics. The use of new research helps make big decisions when it comes to drug treatments and meeting other business objectives. A virtual advisory board can help pharma companies better collaborate with clinicians as they build out these new strategies.
In the following case study, we examine one way a pharma company was able to meaningfully interact with clinicians within a tight timeframe. Over a period of 17 days, the pharma company was able to gather information from 11 KOLs that provided greater clarity into therapy selection.
The virtual advisory board allows for a sharp focus on a finite set of questions,and promotes a flow of thought that can be most provocative in stimulating abroad-ranging discourse.Key Opinion Leader